Skip to main content
SpringerLink
Log in

Glioblastoma multiforme: another potential application for 68Ga-PSMA PET/CT as a guide for targeted therapy

  • Image of the Month
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

A Correction to this article was published on 15 November 2019

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Change history

  • 15 November 2019

    The author names of the original version of this article were inadvertently interchanged. Correct author names are presented here.

References

  1. Nomura N, Pastorino S, Jiang P, et al. Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases. Cancer Cell Int. 2014;14:26.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Demirci E, Ocak M, Kabasakal L, et al. (68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma. Eur J Nucl Med Mol Imaging. 2014;41:1461–2.

    Article  PubMed  Google Scholar 

  3. Sasikumar A, Joy A, Nanabala R, et al. 68Ga-PSMA PET/CT imaging in primary hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2016;43:795–6.

    Article  PubMed  Google Scholar 

  4. Wernicke AG, Edgar MA, Lavi E, et al. Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme. Arch Pathol Lab Med. 2011;135:1486–9.

    Article  PubMed  Google Scholar 

  5. Salas Fragomeni RA, Menke JR, Holdhoff M, et al. Prostate-specific membrane antigen-targeted imaging with [18F]DCFPyL in high-grade gliomas. Clin Nucl Med. 2017;42:e433–5.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Dr. Joanna Mączewska for the 18F-FDG study.

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Medical University of Warsaw, ul. Banacha 1 a, 02-097, Warsaw, Poland

    Jolanta Kunikowska & Królicki Leszek

  2. Department of Neuro-Oncology, The Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland

    Królicki Bartosz

Authors
  1. Jolanta Kunikowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Królicki Bartosz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Królicki Leszek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jolanta Kunikowska.

Ethics declarations

Conflicts of interest

None.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This article does not describe any studies with animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kunikowska, J., Bartosz, K. & Leszek, K. Glioblastoma multiforme: another potential application for 68Ga-PSMA PET/CT as a guide for targeted therapy. Eur J Nucl Med Mol Imaging 45, 886–887 (2018). https://doi.org/10.1007/s00259-018-3934-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-018-3934-2

Keywords

Search

Navigation